Susquehanna Portfolio Strategies, LLC Vanda Pharmaceuticals Inc. Transaction History
Susquehanna Portfolio Strategies, LLC
- $6.3 Trillion
- Q3 2025
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 111,340 shares of VNDA stock, worth $483,215. This represents 0.01% of its overall portfolio holdings.
Number of Shares
111,340
Previous 97,059
14.71%
Holding current value
$483,215
Previous $458 Million
21.28%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding VNDA
# of Institutions
153Shares Held
45MCall Options Held
103KPut Options Held
158K-
Black Rock Inc. New York, NY8.14MShares$35.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$15.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.48MShares$15.1 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.12MShares$13.5 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.56MShares$11.1 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $245M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...